Synthesis, Characterization, PXRD Studies, Theoretical Calculation, and Antitumor Potency Studies of a Novel N,O-Multidentate Chelating Ligand and Its Zr(IV), V(IV), Ru(III), and Cd(II) Complexes

A new series of Zr(IV), V(IV), Ru(III), and Cd(II) complexes with the ligand N-((5-hydroxy-4-oxo-4H-pyran-3-yl)methylene)-2-(p-tolylamino)acetohydrazide (H2L) have been prepared. FT-IR, 1H-NMR, electronic spectra, powder X-ray, and thermal behavior methods were applied to elucidate the structural co...

Full description

Saved in:
Bibliographic Details
Main Authors: Hussein H. Elganzory, Safaa S. Hassan, Samar A. Aly, Ehab M. Abdalla
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Bioinorganic Chemistry and Applications
Online Access:http://dx.doi.org/10.1155/2022/2006451
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849401873115643904
author Hussein H. Elganzory
Safaa S. Hassan
Samar A. Aly
Ehab M. Abdalla
author_facet Hussein H. Elganzory
Safaa S. Hassan
Samar A. Aly
Ehab M. Abdalla
author_sort Hussein H. Elganzory
collection DOAJ
description A new series of Zr(IV), V(IV), Ru(III), and Cd(II) complexes with the ligand N-((5-hydroxy-4-oxo-4H-pyran-3-yl)methylene)-2-(p-tolylamino)acetohydrazide (H2L) have been prepared. FT-IR, 1H-NMR, electronic spectra, powder X-ray, and thermal behavior methods were applied to elucidate the structural composition of new compounds. Geometry optimization for all synthesized compounds was conducted using the Gaussian09 program via the DFT method, to obtain optimal structures and essential parameters. Moreover, the antibacterial and antitumor activity of the ligand and its complexes were studied, where the Cd(II) complex acquires probably the best antibacterial activity followed by the Ru(III) complex towards bacterial species than others when using ampicillin and gentamicin were used as standard drugs. The complexes exhibited interestingly antitumor potential against the MCF-7 breast cancer cell line. The cytotoxicity of the new complexes has been arranged to follow the order: Ru(III) complex > Cd(II) complex > Zr(IV) complex > V(IV) complex > ligand. Molecular docking was performed on the active site of ribosyltransferase and obtained good results. Structure-based molecular docking is used to identify a potential therapeutic inhibitor for NUDT5.
format Article
id doaj-art-8c4daccec87a4bce9e3acdefc66d83d0
institution Kabale University
issn 1687-479X
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Bioinorganic Chemistry and Applications
spelling doaj-art-8c4daccec87a4bce9e3acdefc66d83d02025-08-20T03:37:41ZengWileyBioinorganic Chemistry and Applications1687-479X2022-01-01202210.1155/2022/2006451Synthesis, Characterization, PXRD Studies, Theoretical Calculation, and Antitumor Potency Studies of a Novel N,O-Multidentate Chelating Ligand and Its Zr(IV), V(IV), Ru(III), and Cd(II) ComplexesHussein H. Elganzory0Safaa S. Hassan1Samar A. Aly2Ehab M. Abdalla3Department of ChemistryChemistry DepartmentDepartment of Environmental BiotechnologyChemistry DepartmentA new series of Zr(IV), V(IV), Ru(III), and Cd(II) complexes with the ligand N-((5-hydroxy-4-oxo-4H-pyran-3-yl)methylene)-2-(p-tolylamino)acetohydrazide (H2L) have been prepared. FT-IR, 1H-NMR, electronic spectra, powder X-ray, and thermal behavior methods were applied to elucidate the structural composition of new compounds. Geometry optimization for all synthesized compounds was conducted using the Gaussian09 program via the DFT method, to obtain optimal structures and essential parameters. Moreover, the antibacterial and antitumor activity of the ligand and its complexes were studied, where the Cd(II) complex acquires probably the best antibacterial activity followed by the Ru(III) complex towards bacterial species than others when using ampicillin and gentamicin were used as standard drugs. The complexes exhibited interestingly antitumor potential against the MCF-7 breast cancer cell line. The cytotoxicity of the new complexes has been arranged to follow the order: Ru(III) complex > Cd(II) complex > Zr(IV) complex > V(IV) complex > ligand. Molecular docking was performed on the active site of ribosyltransferase and obtained good results. Structure-based molecular docking is used to identify a potential therapeutic inhibitor for NUDT5.http://dx.doi.org/10.1155/2022/2006451
spellingShingle Hussein H. Elganzory
Safaa S. Hassan
Samar A. Aly
Ehab M. Abdalla
Synthesis, Characterization, PXRD Studies, Theoretical Calculation, and Antitumor Potency Studies of a Novel N,O-Multidentate Chelating Ligand and Its Zr(IV), V(IV), Ru(III), and Cd(II) Complexes
Bioinorganic Chemistry and Applications
title Synthesis, Characterization, PXRD Studies, Theoretical Calculation, and Antitumor Potency Studies of a Novel N,O-Multidentate Chelating Ligand and Its Zr(IV), V(IV), Ru(III), and Cd(II) Complexes
title_full Synthesis, Characterization, PXRD Studies, Theoretical Calculation, and Antitumor Potency Studies of a Novel N,O-Multidentate Chelating Ligand and Its Zr(IV), V(IV), Ru(III), and Cd(II) Complexes
title_fullStr Synthesis, Characterization, PXRD Studies, Theoretical Calculation, and Antitumor Potency Studies of a Novel N,O-Multidentate Chelating Ligand and Its Zr(IV), V(IV), Ru(III), and Cd(II) Complexes
title_full_unstemmed Synthesis, Characterization, PXRD Studies, Theoretical Calculation, and Antitumor Potency Studies of a Novel N,O-Multidentate Chelating Ligand and Its Zr(IV), V(IV), Ru(III), and Cd(II) Complexes
title_short Synthesis, Characterization, PXRD Studies, Theoretical Calculation, and Antitumor Potency Studies of a Novel N,O-Multidentate Chelating Ligand and Its Zr(IV), V(IV), Ru(III), and Cd(II) Complexes
title_sort synthesis characterization pxrd studies theoretical calculation and antitumor potency studies of a novel n o multidentate chelating ligand and its zr iv v iv ru iii and cd ii complexes
url http://dx.doi.org/10.1155/2022/2006451
work_keys_str_mv AT husseinhelganzory synthesischaracterizationpxrdstudiestheoreticalcalculationandantitumorpotencystudiesofanovelnomultidentatechelatingligandanditszrivvivruiiiandcdiicomplexes
AT safaashassan synthesischaracterizationpxrdstudiestheoreticalcalculationandantitumorpotencystudiesofanovelnomultidentatechelatingligandanditszrivvivruiiiandcdiicomplexes
AT samaraaly synthesischaracterizationpxrdstudiestheoreticalcalculationandantitumorpotencystudiesofanovelnomultidentatechelatingligandanditszrivvivruiiiandcdiicomplexes
AT ehabmabdalla synthesischaracterizationpxrdstudiestheoreticalcalculationandantitumorpotencystudiesofanovelnomultidentatechelatingligandanditszrivvivruiiiandcdiicomplexes